Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Koki Tokunaga"'
Autor:
Miki Uwatoko, Koki Tokunaga, Mako Kawano, Masahisa Kamimura, Yutaro Ibi, Masayuki Otsuka, Masato Minami, Haruhito Yoshimine, Fujio Hamada, Akio Ido
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Abstract Background Neurological symptoms sometimes occur in hemodialysis patients, with causes including cerebral infarction, cerebral hemorrhaging, meningitis, and encephalitis. Dialysis disequilibrium syndrome (DDS) is widely known as a complicati
Externí odkaz:
https://doaj.org/article/7d380874688f48b8825a8dacfc68cad2
Autor:
Koki Tokunaga, Akio Ido, Masato Minami, Yutaro Ibi, Haruhito Yoshimine, Mai Nakahara, Shiroh Tanoue, Shuji Kanmura
Publikováno v:
Clinical and Experimental Nephrology. 25:935-943
Peritoneal dialysis (PD) is essential for patients with end-stage renal disease. Peritoneal fibrosis (PF) is a complex inflammatory, fibrogenic process. No effective treatments are available to prevent these processes. Hepatocyte growth factor (HGF)
Autor:
Kazutaka Matsushita, Shigeyuki Miyamura, Hirotaka Komaba, Koki Tokunaga, Shoma Tanaka, Takehiro Nakano, Masaki Otagiri, Toru Maruyama, Motoko Tanaka, Tadashi Imafuku, Hitoshi Maeda, Kenshiro Hirata, Masafumi Fukagawa, Daisuke Kadowaki, Hiroshi Watanabe, Hiromasa Kato
Publikováno v:
Biological and Pharmaceutical Bulletin. 43:1583-1590
Chronic kidney disease (CKD) patients with secondary hyperparathyroidism (SHPT) have an increased risk of cardiovascular disease (CVD). Cinacalcet is a calcimimetic that permits impaired endothelial functions to be recovered via inhibiting parathyroi
Autor:
Masayuki Otsuka, Koki Tokunaga, Miki Uwatoko, Akio Ido, Haruhito Yoshimine, Mako Kawano, Fujio Hamada, Yutaro Ibi, Masahisa Kamimura, Masato Minami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Background Neurological symptoms sometimes occur in hemodialysis patients, with causes including cerebral infarction, cerebral hemorrhaging, meningitis, and encephalitis. Dialysis disequilibrium syndrome (DDS) is widely known as a complication of hem
Autor:
Manei Oku, Yozo Yoshimine, Atsushi Sogabe, Masaharu Abe, Miki Uwatoko, Rei Obo, Haruhito Yoshimine, Yoshio Uchida, Tsuyoshi Nosaki, Akio Ido, Koki Tokunaga, Akiyuki Otsuka
Publikováno v:
Nihon Toseki Igakkai Zasshi. 52:363-368
Autor:
Koki Tokunaga, Miki Uwatoko, Yawara Yamashita, Akio Ido, Fujio Hamada, Emiko Mizuma, Haruhito Yoshimine, Masaharu Abe, Shin Uruta, Takuya Kubo
Publikováno v:
Nihon Toseki Igakkai Zasshi. 51:401-408
Autor:
Fujio Umehara, Yoshio Uchida, Miho Inomata, Mayumi Fukumoto, Atsushi Sogabe, Koki Tokunaga, Akio Ido
Publikováno v:
Nihon Toseki Igakkai Zasshi. 50:555-559
Autor:
Hideki Enokida, Akihiko Mitsuke, Mai Nakahara, Norihiko Goto, Masato Minami, Yasutoshi Yamada, Yumi Oda, Emiko Mizuma, Haruhito Yoshimine, Akio Ido, Kosuke Masutani, Koki Tokunaga
Publikováno v:
CEN Case Rep
A 52-year-old woman had been found to have hematuria at her annual checkup 5 years in a row. She hoped to donate her kidney to her husband, so we performed a percutaneous kidney biopsy at our department. It was difficult for us to detect apparent abn
Autor:
Hirofumi Higashi, Shigeho Maenohara, Akio Ido, Osamu Kubozono, Seiichi Mawatari, Koki Tokunaga, Kohei Oda, Ichiro Kanetsuki, Takuya Hiwaki, Kotaro Kumagai, Takeshi Kure, Hirofumi Uto, Yasunari Hiramine, Yasushi Imamura, Sho Ijuin
Publikováno v:
Hepatology Research. 47:542-557
Aim Tolvaptan, oral active vasopressin V2 receptor antagonist is widely used for hepatic edema in Japan, but its clinical benefits have yet to be fully clarified. Present study evaluated the efficacy of tolvaptan in hepatic edema. Methods The efficac
Autor:
Yoshiro Muraoka, Masato Minami, Akio Ido, Mai Nakahara, Takuma Kojo, Koki Tokunaga, Yozo Yoshimine, Masaharu Abe, Miho Inomata, Miki Oyamada, Hiroyuki Deguchi, Yumi Oda
Publikováno v:
Nihon Toseki Igakkai Zasshi. 49:241-246